Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, Hubei, PR. China.
Faculty of Pharmacy, University of Strasbourg-CNRS, Illkirch, France.
Autophagy. 2020 Mar;16(3):419-434. doi: 10.1080/15548627.2019.1628520. Epub 2019 Jun 16.
Mitophagy, which is a conserved cellular process for selectively removing damaged or unwanted mitochondria, is critical for mitochondrial quality control and the maintenance of normal cellular physiology. However, the precise mechanisms underlying mitophagy remain largely unknown. Prior studies on mitophagy focused on the events in the mitochondrial outer membrane. PHB2 (prohibitin 2), which is a highly conserved membrane scaffold protein, was recently identified as a novel inner membrane mitophagy receptor that mediates mitophagy. Here, we report a new signaling pathway for PHB2-mediated mitophagy. Upon mitochondrial membrane depolarization or misfolded protein aggregation, PHB2 depletion destabilizes PINK1 in the mitochondria, which blocks the mitochondrial recruitment of PRKN/Parkin, ubiquitin and OPTN (optineurin), leading to an inhibition of mitophagy. In addition, PHB2 overexpression directly induces PRKN recruitment to the mitochondria. Moreover, PHB2-mediated mitophagy is dependent on the mitochondrial inner membrane protease PARL, which interacts with PHB2 and is activated upon PHB2 depletion. Furthermore, PGAM5, which is processed by PARL, participates in PHB2-mediated PINK1 stabilization. Finally, a ligand of PHB proteins that we synthesized, called FL3, was found to strongly inhibit PHB2-mediated mitophagy and to effectively block cancer cell growth and energy production at nanomolar concentrations. Thus, our findings reveal that the PHB2-PARL-PGAM5-PINK1 axis is a novel pathway of PHB2-mediated mitophagy and that targeting PHB2 with the chemical compound FL3 is a promising strategy for cancer therapy.: AIFM1: apoptosis inducing factor mitochondria associated 1; ATP5F1A/ATP5A1: ATP synthase F1 subunit alpha; BAF: bafilomycin A; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2; CCCP: chemical reagent carbonyl cyanide m-chlorophenyl hydrazine; FL3: flavaglines compound 3; HSPD1/HSP60: heat shock protein family D (Hsp60) member 1; LC3B/MAP1LC3B: microtubule associated protein 1 light chain 3 beta; MEF: mouse embryo fibroblasts; MPP: mitochondrial-processing peptidase; MT-CO2/COX2: mitochondrially encoded cytochrome c oxidase II; MTS: mitochondrial targeting sequence; OA: oligomycin and antimycin A; OPTN: optineurin; OTC: ornithine carbamoyltransferase; PARL: presenilin associated rhomboid like; PBS: phosphate-buffered saline; PGAM5: PGAM family member 5, mitochondrial serine/threonine protein phosphatase; PHB: prohibitin; PHB2: prohibitin 2; PINK1: PTEN induced kinase 1; PRKN/Parkin: parkin RBR E3 ubiquitin protein ligase; Roc-A: rocaglamide A; TOMM20: translocase of outer mitochondrial membrane 20; TUBB: tubulin beta class I.
自噬,一种选择性清除受损或不需要的线粒体的保守细胞过程,对于线粒体质量控制和维持正常细胞生理功能至关重要。然而,自噬的确切机制在很大程度上仍然未知。先前的自噬研究主要集中在线粒体外膜的事件上。PHB2(阻遏素 2),一种高度保守的膜支架蛋白,最近被鉴定为一种新的内膜自噬受体,介导自噬。在这里,我们报告了一个新的 PHB2 介导的自噬信号通路。在线粒体去极化或错误折叠的蛋白质聚集时,PHB2 的耗竭会使 PINK1 在线粒体中不稳定,从而阻止 PRKN/Parkin、泛素和 OPTN(optineurin)在线粒体上的募集,从而抑制自噬。此外,PHB2 的过表达直接诱导 PRKN 向线粒体的募集。此外,PHB2 介导的自噬依赖于线粒体内膜蛋白酶 PARL,PARL 与 PHB2 相互作用,并在 PHB2 耗竭时被激活。此外,PGAM5,一种被 PARL 加工的蛋白,参与 PHB2 介导的 PINK1 稳定。最后,我们合成了一种 PHB 蛋白的配体,称为 FL3,发现它强烈抑制 PHB2 介导的自噬,并以纳摩尔浓度有效地阻断癌细胞的生长和能量产生。因此,我们的研究结果表明,PHB2-PARL-PGAM5-PINK1 轴是 PHB2 介导的自噬的一个新途径,用化学化合物 FL3 靶向 PHB2 是癌症治疗的一种很有前途的策略。AIFM1:凋亡诱导因子线粒体相关 1;ATP5F1A/ATP5A1:ATP 合酶 F1 亚基 alpha;BAF:巴弗霉素 A;CALCOCO2/NDP52:钙结合和卷曲螺旋结构域 2;CCCP:化学试剂羰基氰化物 m-氯苯腙;FL3:flavaglines 化合物 3;HSPD1/HSP60:热休克蛋白家族 D(Hsp60)成员 1;LC3B/MAP1LC3B:微管相关蛋白 1 轻链 3 beta;MEF:鼠胚胎成纤维细胞;MPP:线粒体加工肽酶;MT-CO2/COX2:线粒体编码细胞色素 c 氧化酶 II;MTS:线粒体靶向序列;OA:寡霉素和抗霉素 A;OPTN:optineurin;OTC:鸟氨酸氨甲酰转移酶;PARL:早老素相关的类环指蛋白;PBS:磷酸盐缓冲盐水;PGAM5:PGAM 家族成员 5,线粒体丝氨酸/苏氨酸蛋白磷酸酶;PHB:阻遏素;PHB2:阻遏素 2;PINK1:PTEN 诱导的激酶 1;PRKN/Parkin:Parkin RBR E3 泛素蛋白连接酶;Roc-A:rocaglamide A;TOMM20:外线粒体膜转运蛋白 20;TUBB:微管蛋白 beta 类 I。